CLINICAL_TRIALS
trial_result
· 2025-05-13
Clinical Trial Update: Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 trial results evaluating acalabrutinib after blood or marrow transplantation in mantle cell lymphoma; results posted in May 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SCRI Development Innovations, LLC | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2025-05-13